Phenotypic analysis of an MLL-AF4 gene regulatory network reveals indirect CASP9 repression as a mode of inducing apoptosis resistance.
Joe R. HarmaniD, Ross ThorneiD, Max Jamilly, Marta Cecylia TapiaiD, Nicholas T. CrumpiD, Siobhan RiceiD, Ryan D. D. BeveridgeiD, Edward R. MorrisseyiD, Marella F. T. R. De BruijniD, Irene A.G. RobertsiD, Anindita RoyiD, Tudor A. FulgaiD, Thomas A. MilneiD
Abstract
Regulatory interactions mediated by transcription factors (TFs) make up complex networks that control cellular behavior. Fully understanding these gene regulatory networks (GRNs) offers greater insight into the consequences of disease-causing perturbations than studying single TF binding events in isolation. Chromosomal translocations of the Mixed Lineage Leukemia gene (MLL) produce MLL fusion proteins such as MLL-AF4, causing poor prognosis acute lymphoblastic leukemias (ALLs). MLL-AF4 is thought to drive leukemogenesis by directly binding to genes and inducing aberrant overexpression of key gene targets, including anti-apoptotic factors such as BCL-2. However, this model minimizes the potential for circuit generated regulatory outputs, including gene repression. To better understand the MLL-AF4 driven regulatory landscape, we integrated ChIP-seq, patient RNA-seq and CRISPR essentiality screens to generate a model GRN. This GRN identified several key transcription factors, including RUNX1, that regulate target genes using feed-forward loop and cascade motifs. We used CRISPR screening in the presence of the BCL-2 inhibitor venetoclax to identify functional impacts on apoptosis. This identified an MLL-AF4:RUNX1 cascade that represses CASP9, perturbation of which disrupts venetoclax induced apoptosis. This illustrates how our GRN can be used to better understand potential mechanisms of drug resistance acquisition. Graphical abstract caption O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=149 SRC="FIGDIR/small/179796v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@cca8f2org.highwire.dtl.DTLVardef@67b289org.highwire.dtl.DTLVardef@1fa44aeorg.highwire.dtl.DTLVardef@1b32487_HPS_FORMAT_FIGEXP M_FIG A network model of the MLL-AF4 regulatory landscape identifies feed-forward loop and cascade motifs. Functional screening using CRISPR and venetoclax identified an MLL-AF4:RUNX1:CASP9 repressive cascade that impairs drug-induced cell death. C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 31
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Post-transcriptional gene regulation by the RNA binding protein IGF2BP3 is critical for MLL-AF4 mediated leukemogenesis
T. M. Tran, J. Philipp, … D. S. Rao·bioRxiv·Dec 20, 2020
- A microRNA expression signature in infant t(4;11) MLL-AF4+ BCP-ALL uncovers novel therapeutic targets
C. Malouf, A. Duguid, … K. Ottersbach·bioRxiv·Jan 12, 2023
- A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition
Y. M. Soto-Feliciano, F. J. Sanchez-Rivera, … C. D. Allis·bioRxiv·Oct 22, 2021
- Epigenetic regulator genes direct lineage switching in MLL-AF4 leukaemia
R. Tirtakusuma, K. Szoltysek, … M. J Thirman·bioRxiv·Jul 16, 2021
- Therapy resistance in AML is mediated by cytoplasmic sequestration of the transcriptional repressor IRF2BP2
Mark Jordan Althoff, Mohd Minhajuddin, … Craig T. Jordan·bioRxiv·May 22, 2025
- MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
F. Brown, E. Still, … A. Kentsis·bioRxiv·Feb 9, 2017